Madrigal Statement on the Passing of Dr. Stephen Harrison
Madrigal Statement on the Passing of Dr. Stephen Harrison
CONSHOHOCKEN, Pa., April 24, 2024 (GLOBE NEWSWIRE) -- The Madrigal team is shocked and saddened to learn of the passing of Dr. Stephen Harrison.
賓夕法尼亞州康舍霍肯，2024年4月24日（GLOBE NEWSWIRE）——得知斯蒂芬·哈里森博士去世，Madrigal團隊感到震驚和悲傷。
We offer our deepest condolences to Stephen's family for their loss.
我們對斯蒂芬的家人損失表示最深切的慰問。
Stephen was a colleague and friend to so many of us at Madrigal. He worked tirelessly to improve the lives of people with nonalcoholic steatohepatitis (NASH), and his contributions to the field will touch countless families across the globe for decades to come. So many of the recent innovations and achievements we've seen in NASH research stemmed from his constant collaboration with partners in academia, industry, the regulatory sciences, and the patient community.
Stephen 是 Madrigal 許多人的同事和朋友。他孜孜不倦地努力改善非酒精性脂肪肝炎（NASH）患者的生活，他在該領域的貢獻將在未來幾十年內影響全球無數家庭。我們在NASH研究中看到的許多最新創新和成就都源於他與學術界、工業界、監管科學和患者社區合作伙伴的持續合作。
Stephen was much more than a brilliant investigator and physician; he was a true leader who inspired all of us with his commitment to patients. We'll remember his sense of humor, his courtesy, and his boundless energy and optimism.
斯蒂芬不僅是一位出色的調查員和醫生；他是一位真正的領導者，他對患者的承諾激勵了我們所有人。我們會記住他的幽默感、禮貌，以及他無限的活力和樂觀情緒。
The field of hepatology has lost a true giant.
肝病學領域已經失去了一位真正的巨頭。
Source: Madrigal Pharmaceuticals, Inc.
來源：Madrigal Pharmicals, Inc.
譯文內容由第三人軟體翻譯。